Last C$0.57 CAD
Change Today 0.00 / 0.00%
Volume 132.8K
TH On Other Exchanges
Symbol
Exchange
Toronto
OTC US
Frankfurt
As of 3:45 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

theratechnologies inc (TH) Snapshot

Open
C$0.57
Previous Close
C$0.57
Day High
C$0.59
Day Low
C$0.56
52 Week High
04/30/14 - C$0.65
52 Week Low
09/25/13 - C$0.19
Market Cap
34.8M
Average Volume 10 Days
66.0K
EPS TTM
C$-0.10
Shares Outstanding
61.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERATECHNOLOGIES INC (TH)

Related News

No related news articles were found.

theratechnologies inc (TH) Related Businessweek News

No Related Businessweek News Found

theratechnologies inc (TH) Details

Theratechnologies Inc., a biopharmaceutical company, develops and commercializes therapeutic peptide products. The company’s lead product is EGRIFTA (tesamorelin for injection), an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in the United States. It also focuses on commercializing EGRIFTA in Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, Thailand, and certain central Asian countries. Theratechnologies Inc. also has TH1173, a second-generation GRF peptide that has completed preclinical studies in its product pipeline. The company was founded in 1993 and is headquartered in Montréal, Canada.

Founded in 1993

theratechnologies inc (TH) Top Compensated Officers

Chief Executive Officer, President and Non-In...
Total Annual Compensation: C$376.0K
Vice President of Finance
Total Annual Compensation: C$170.0K
Vice President of Legal Affairs and Secretary
Total Annual Compensation: C$233.0K
Vice President of Pharmaceutical Development
Total Annual Compensation: C$211.5K
Special Counsel to the President and Chief Ex...
Total Annual Compensation: C$213.6K
Compensation as of Fiscal Year 2013.

theratechnologies inc (TH) Key Developments

Theratechnologies Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended May 31, 2014

Theratechnologies Inc. announced unaudited consolidated financial results for the second quarter and six months ended May 31, 2014. For the quarter, the company reported revenue of CAD 2,393,000 against CAD 2,331,000 in the comparable periods of fiscal 2013. Taking into account the revenue and expense variations, the net profit was CAD 1,007,000, compared to a net loss of CAD 1,382,000 in the comparable period of fiscal 2013. On a per share basis, the net profit was CAD 0.02 compared to net loss of CAD 0.02 in the comparable period of fiscal 2013. Cash flows used in operating activities were CAD 3,474,000 against CAD 4,071,000 a year ago. Loss from operating activities was CAD 3,260,000 compared with CAD 1,500,000 a year ago. Profit before income taxes was CAD 1,019,000 compared with loss of CAD 1,365,000 a year ago. Acquisition of intangible assets was CAD 487,000. For the six months, the company reported revenue of CAD 4,065,000 compared to CAD 4,130,000 in the comparable periods of fiscal 2013. Net loss was CAD 2,527,000 or CAD 0.04 per share compared to a net profit of CAD 478,000 or CAD 0.01 per share in the comparable period of fiscal 2013. Cash flows used in operating activities were CAD 5,779,000 compared to CAD 6,955,000 in the comparable periods of fiscal 2013. Loss from operating activities was CAD 6,858,000 compared with profit of CAD 240,000 a year ago. Loss before income taxes was CAD 2,507,000 compared with profit of CAD 495,000 a year ago. Acquisition of intangible assets was CAD 828,000.

Theratechnologies Inc. to Report Q2, 2014 Results on Jul 09, 2014

Theratechnologies Inc. announced that they will report Q2, 2014 results Pre-Market on Jul 09, 2014

Theratechnologies Inc., Q2 2014 Earnings Call, Jul 09, 2014

Theratechnologies Inc., Q2 2014 Earnings Call, Jul 09, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TH:CN C$0.57 CAD 0.00

TH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TH.
View Industry Companies
 

Industry Analysis

TH

Industry Average

Valuation TH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.6x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERATECHNOLOGIES INC, please visit www.theratech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.